398 related articles for article (PubMed ID: 10436010)
1. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.
Alarcon CM; Heitman J; Cardenas ME
Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010
[TBL] [Abstract][Full Text] [Related]
2. Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast.
Alarcon CM; Cardenas ME; Heitman J
Genes Dev; 1996 Feb; 10(3):279-88. PubMed ID: 8595879
[TBL] [Abstract][Full Text] [Related]
3. TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.
Zheng XF; Florentino D; Chen J; Crabtree GR; Schreiber SL
Cell; 1995 Jul; 82(1):121-30. PubMed ID: 7606777
[TBL] [Abstract][Full Text] [Related]
4. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
Lorenz MC; Heitman J
J Biol Chem; 1995 Nov; 270(46):27531-7. PubMed ID: 7499212
[TBL] [Abstract][Full Text] [Related]
5. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression.
Vilella-Bach M; Nuzzi P; Fang Y; Chen J
J Biol Chem; 1999 Feb; 274(7):4266-72. PubMed ID: 9933627
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations at the FKBP12-rapamycin-binding site of TOR1.
Freeman K; Livi GP
Gene; 1996 Jun; 172(1):143-7. PubMed ID: 8654975
[TBL] [Abstract][Full Text] [Related]
7. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.
Sabers CJ; Martin MM; Brunn GJ; Williams JM; Dumont FJ; Wiederrecht G; Abraham RT
J Biol Chem; 1995 Jan; 270(2):815-22. PubMed ID: 7822316
[TBL] [Abstract][Full Text] [Related]
8. TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast.
Helliwell SB; Wagner P; Kunz J; Deuter-Reinhard M; Henriquez R; Hall MN
Mol Biol Cell; 1994 Jan; 5(1):105-18. PubMed ID: 8186460
[TBL] [Abstract][Full Text] [Related]
9. Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.
Stan R; McLaughlin MM; Cafferkey R; Johnson RK; Rosenberg M; Livi GP
J Biol Chem; 1994 Dec; 269(51):32027-30. PubMed ID: 7528205
[TBL] [Abstract][Full Text] [Related]
10. The fission yeast TOR homolog, tor1+, is required for the response to starvation and other stresses via a conserved serine.
Weisman R; Choder M
J Biol Chem; 2001 Mar; 276(10):7027-32. PubMed ID: 11096119
[TBL] [Abstract][Full Text] [Related]
11. FAP1, a homologue of human transcription factor NF-X1, competes with rapamycin for binding to FKBP12 in yeast.
Kunz J; Loeschmann A; Deuter-Reinhard M; Hall MN
Mol Microbiol; 2000 Sep; 37(6):1480-93. PubMed ID: 10998178
[TBL] [Abstract][Full Text] [Related]
12. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity.
Sabatini DM; Pierchala BA; Barrow RK; Schell MJ; Snyder SH
J Biol Chem; 1995 Sep; 270(36):20875-8. PubMed ID: 7673106
[TBL] [Abstract][Full Text] [Related]
13. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.
Sabatini DM; Erdjument-Bromage H; Lui M; Tempst P; Snyder SH
Cell; 1994 Jul; 78(1):35-43. PubMed ID: 7518356
[TBL] [Abstract][Full Text] [Related]
14. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.
Loewith R; Jacinto E; Wullschleger S; Lorberg A; Crespo JL; Bonenfant D; Oppliger W; Jenoe P; Hall MN
Mol Cell; 2002 Sep; 10(3):457-68. PubMed ID: 12408816
[TBL] [Abstract][Full Text] [Related]
15. A mammalian protein targeted by G1-arresting rapamycin-receptor complex.
Brown EJ; Albers MW; Shin TB; Ichikawa K; Keith CT; Lane WS; Schreiber SL
Nature; 1994 Jun; 369(6483):756-8. PubMed ID: 8008069
[TBL] [Abstract][Full Text] [Related]
16. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002.
Brunn GJ; Williams J; Sabers C; Wiederrecht G; Lawrence JC; Abraham RT
EMBO J; 1996 Oct; 15(19):5256-67. PubMed ID: 8895571
[TBL] [Abstract][Full Text] [Related]
17. Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity.
Cafferkey R; Young PR; McLaughlin MM; Bergsma DJ; Koltin Y; Sathe GM; Faucette L; Eng WK; Johnson RK; Livi GP
Mol Cell Biol; 1993 Oct; 13(10):6012-23. PubMed ID: 8413204
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
Cruz MC; Cavallo LM; Görlach JM; Cox G; Perfect JR; Cardenas ME; Heitman J
Mol Cell Biol; 1999 Jun; 19(6):4101-12. PubMed ID: 10330150
[TBL] [Abstract][Full Text] [Related]
19. TOR controls translation initiation and early G1 progression in yeast.
Barbet NC; Schneider U; Helliwell SB; Stansfield I; Tuite MF; Hall MN
Mol Biol Cell; 1996 Jan; 7(1):25-42. PubMed ID: 8741837
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin resistance in ataxia-telangiectasia.
Beamish H; Williams R; Chen P; Khanna KK; Hobson K; Watters D; Shiloh Y; Lavin M
Oncogene; 1996 Sep; 13(5):963-70. PubMed ID: 8806686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
